ディフェンシンのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Defensin Market Insights, Forecast to 2028

• レポートコード：QY2207C3867 • 出版社/出版日：QYResearch / 2022年7月11日 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のディフェンシンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にディフェンシンの世界市場のxxx％を占める「α-ディフェンシン」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「科学研究」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のディフェンシンの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのディフェンシン市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのディフェンシン市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 ディフェンシンのグローバル主要メーカーには、Hycult Biotech、Cloud Clone、GL Biochem、Peptide Institute、Go Top Peptide Biotech、Cedarlane、ProSpec-Tany、Abbexa、AnaSpec、Hangzhou Taijia Biotechなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ディフェンシン市場は、種類と用途によって区分されます。世界のディフェンシン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 α-ディフェンシン、β-ディフェンシン 【用途別セグメント】 科学研究、医療、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ディフェンシン製品概要 - 種類別市場（α-ディフェンシン、β-ディフェンシン） - 用途別市場（科学研究、医療、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のディフェンシン販売量予測2017-2028 - 世界のディフェンシン売上予測2017-2028 - ディフェンシンの地域別販売量 - ディフェンシンの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ディフェンシン販売量 - 主要メーカー別ディフェンシン売上 - 主要メーカー別ディフェンシン価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（α-ディフェンシン、β-ディフェンシン） - ディフェンシンの種類別販売量 - ディフェンシンの種類別売上 - ディフェンシンの種類別価格 ・用途別市場規模（科学研究、医療、その他） - ディフェンシンの用途別販売量 - ディフェンシンの用途別売上 - ディフェンシンの用途別価格 ・北米市場 - 北米のディフェンシン市場規模（種類別、用途別） - 主要国別のディフェンシン市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのディフェンシン市場規模（種類別、用途別） - 主要国別のディフェンシン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のディフェンシン市場規模（種類別、用途別） - 主要国別のディフェンシン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のディフェンシン市場規模（種類別、用途別） - 主要国別のディフェンシン市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのディフェンシン市場規模（種類別、用途別） - 主要国別のディフェンシン市場規模（トルコ、サウジアラビア） ・企業情報 Hycult Biotech、Cloud Clone、GL Biochem、Peptide Institute、Go Top Peptide Biotech、Cedarlane、ProSpec-Tany、Abbexa、AnaSpec、Hangzhou Taijia Biotech ・産業チェーン及び販売チャネル分析 - ディフェンシンの産業チェーン分析 - ディフェンシンの原材料 - ディフェンシンの生産プロセス - ディフェンシンの販売及びマーケティング - ディフェンシンの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ディフェンシンの産業動向 - ディフェンシンのマーケットドライバー - ディフェンシンの課題 - ディフェンシンの阻害要因 ・主な調査結果

Market Analysis and Insights: Global Defensin Market
Due to the COVID-19 pandemic, the global Defensin market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, α-Defensin accounting for % of the Defensin global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Scientific Research segment is altered to an % CAGR throughout this forecast period.
China Defensin market size is valued at US$ million in 2021, while the US and Europe Defensin are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Defensin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Defensin include Hycult Biotech, Cloud Clone, GL Biochem, Peptide Institute, Go Top Peptide Biotech, Cedarlane, ProSpec-Tany, Abbexa and AnaSpec and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Defensin Scope and Segment
Defensin market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Defensin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
α-Defensin
β-Defensin
Segment by Application
Scientific Research
Medical
Others
By Company
Hycult Biotech
Cloud Clone
GL Biochem
Peptide Institute
Go Top Peptide Biotech
Cedarlane
ProSpec-Tany
Abbexa
AnaSpec
Hangzhou Taijia Biotech
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Defensin Product Introduction
1.2 Market by Type
1.2.1 Global Defensin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 α-Defensin
1.2.3 β-Defensin
1.3 Market by Application
1.3.1 Global Defensin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Scientific Research
1.3.3 Medical
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Defensin Sales Estimates and Forecasts 2017-2028
2.2 Global Defensin Revenue Estimates and Forecasts 2017-2028
2.3 Global Defensin Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Defensin Sales by Region
2.4.1 Global Defensin Sales by Region (2017-2022)
2.4.2 Global Sales Defensin by Region (2023-2028)
2.5 Global Defensin Revenue by Region
2.5.1 Global Defensin Revenue by Region (2017-2022)
2.5.2 Global Defensin Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Defensin Sales by Manufacturers
3.1.1 Global Top Defensin Manufacturers by Sales (2017-2022)
3.1.2 Global Defensin Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Defensin in 2021
3.2 Global Defensin Revenue by Manufacturers
3.2.1 Global Defensin Revenue by Manufacturers (2017-2022)
3.2.2 Global Defensin Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Defensin Revenue in 2021
3.3 Global Defensin Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Defensin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Defensin Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Defensin Sales by Type
4.1.1 Global Defensin Historical Sales by Type (2017-2022)
4.1.2 Global Defensin Forecasted Sales by Type (2023-2028)
4.1.3 Global Defensin Sales Market Share by Type (2017-2028)
4.2 Global Defensin Revenue by Type
4.2.1 Global Defensin Historical Revenue by Type (2017-2022)
4.2.2 Global Defensin Forecasted Revenue by Type (2023-2028)
4.2.3 Global Defensin Revenue Market Share by Type (2017-2028)
4.3 Global Defensin Price by Type
4.3.1 Global Defensin Price by Type (2017-2022)
4.3.2 Global Defensin Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Defensin Sales by Application
5.1.1 Global Defensin Historical Sales by Application (2017-2022)
5.1.2 Global Defensin Forecasted Sales by Application (2023-2028)
5.1.3 Global Defensin Sales Market Share by Application (2017-2028)
5.2 Global Defensin Revenue by Application
5.2.1 Global Defensin Historical Revenue by Application (2017-2022)
5.2.2 Global Defensin Forecasted Revenue by Application (2023-2028)
5.2.3 Global Defensin Revenue Market Share by Application (2017-2028)
5.3 Global Defensin Price by Application
5.3.1 Global Defensin Price by Application (2017-2022)
5.3.2 Global Defensin Price Forecast by Application (2023-2028)
6 North America
6.1 North America Defensin Market Size by Type
6.1.1 North America Defensin Sales by Type (2017-2028)
6.1.2 North America Defensin Revenue by Type (2017-2028)
6.2 North America Defensin Market Size by Application
6.2.1 North America Defensin Sales by Application (2017-2028)
6.2.2 North America Defensin Revenue by Application (2017-2028)
6.3 North America Defensin Market Size by Country
6.3.1 North America Defensin Sales by Country (2017-2028)
6.3.2 North America Defensin Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Defensin Market Size by Type
7.1.1 Europe Defensin Sales by Type (2017-2028)
7.1.2 Europe Defensin Revenue by Type (2017-2028)
7.2 Europe Defensin Market Size by Application
7.2.1 Europe Defensin Sales by Application (2017-2028)
7.2.2 Europe Defensin Revenue by Application (2017-2028)
7.3 Europe Defensin Market Size by Country
7.3.1 Europe Defensin Sales by Country (2017-2028)
7.3.2 Europe Defensin Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Defensin Market Size by Type
8.1.1 Asia Pacific Defensin Sales by Type (2017-2028)
8.1.2 Asia Pacific Defensin Revenue by Type (2017-2028)
8.2 Asia Pacific Defensin Market Size by Application
8.2.1 Asia Pacific Defensin Sales by Application (2017-2028)
8.2.2 Asia Pacific Defensin Revenue by Application (2017-2028)
8.3 Asia Pacific Defensin Market Size by Region
8.3.1 Asia Pacific Defensin Sales by Region (2017-2028)
8.3.2 Asia Pacific Defensin Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Defensin Market Size by Type
9.1.1 Latin America Defensin Sales by Type (2017-2028)
9.1.2 Latin America Defensin Revenue by Type (2017-2028)
9.2 Latin America Defensin Market Size by Application
9.2.1 Latin America Defensin Sales by Application (2017-2028)
9.2.2 Latin America Defensin Revenue by Application (2017-2028)
9.3 Latin America Defensin Market Size by Country
9.3.1 Latin America Defensin Sales by Country (2017-2028)
9.3.2 Latin America Defensin Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Defensin Market Size by Type
10.1.1 Middle East and Africa Defensin Sales by Type (2017-2028)
10.1.2 Middle East and Africa Defensin Revenue by Type (2017-2028)
10.2 Middle East and Africa Defensin Market Size by Application
10.2.1 Middle East and Africa Defensin Sales by Application (2017-2028)
10.2.2 Middle East and Africa Defensin Revenue by Application (2017-2028)
10.3 Middle East and Africa Defensin Market Size by Country
10.3.1 Middle East and Africa Defensin Sales by Country (2017-2028)
10.3.2 Middle East and Africa Defensin Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Hycult Biotech
11.1.1 Hycult Biotech Corporation Information
11.1.2 Hycult Biotech Overview
11.1.3 Hycult Biotech Defensin Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Hycult Biotech Defensin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Hycult Biotech Recent Developments
11.2 Cloud Clone
11.2.1 Cloud Clone Corporation Information
11.2.2 Cloud Clone Overview
11.2.3 Cloud Clone Defensin Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Cloud Clone Defensin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Cloud Clone Recent Developments
11.3 GL Biochem
11.3.1 GL Biochem Corporation Information
11.3.2 GL Biochem Overview
11.3.3 GL Biochem Defensin Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 GL Biochem Defensin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GL Biochem Recent Developments
11.4 Peptide Institute
11.4.1 Peptide Institute Corporation Information
11.4.2 Peptide Institute Overview
11.4.3 Peptide Institute Defensin Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Peptide Institute Defensin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Peptide Institute Recent Developments
11.5 Go Top Peptide Biotech
11.5.1 Go Top Peptide Biotech Corporation Information
11.5.2 Go Top Peptide Biotech Overview
11.5.3 Go Top Peptide Biotech Defensin Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Go Top Peptide Biotech Defensin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Go Top Peptide Biotech Recent Developments
11.6 Cedarlane
11.6.1 Cedarlane Corporation Information
11.6.2 Cedarlane Overview
11.6.3 Cedarlane Defensin Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Cedarlane Defensin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Cedarlane Recent Developments
11.7 ProSpec-Tany
11.7.1 ProSpec-Tany Corporation Information
11.7.2 ProSpec-Tany Overview
11.7.3 ProSpec-Tany Defensin Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 ProSpec-Tany Defensin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 ProSpec-Tany Recent Developments
11.8 Abbexa
11.8.1 Abbexa Corporation Information
11.8.2 Abbexa Overview
11.8.3 Abbexa Defensin Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Abbexa Defensin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Abbexa Recent Developments
11.9 AnaSpec
11.9.1 AnaSpec Corporation Information
11.9.2 AnaSpec Overview
11.9.3 AnaSpec Defensin Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 AnaSpec Defensin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 AnaSpec Recent Developments
11.10 Hangzhou Taijia Biotech
11.10.1 Hangzhou Taijia Biotech Corporation Information
11.10.2 Hangzhou Taijia Biotech Overview
11.10.3 Hangzhou Taijia Biotech Defensin Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Hangzhou Taijia Biotech Defensin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Hangzhou Taijia Biotech Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Defensin Industry Chain Analysis
12.2 Defensin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Defensin Production Mode & Process
12.4 Defensin Sales and Marketing
12.4.1 Defensin Sales Channels
12.4.2 Defensin Distributors
12.5 Defensin Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Defensin Industry Trends
13.2 Defensin Market Drivers
13.3 Defensin Market Challenges
13.4 Defensin Market Restraints
14 Key Findings in The Global Defensin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Defensin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of α-Defensin
Table 3. Major Manufacturers of β-Defensin
Table 4. Global Defensin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Defensin Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Defensin Sales by Region (2017-2022) & (Mg)
Table 7. Global Defensin Sales Market Share by Region (2017-2022)
Table 8. Global Defensin Sales by Region (2023-2028) & (Mg)
Table 9. Global Defensin Sales Market Share by Region (2023-2028)
Table 10. Global Defensin Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Defensin Revenue Market Share by Region (2017-2022)
Table 12. Global Defensin Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Defensin Revenue Market Share by Region (2023-2028)
Table 14. Global Defensin Sales by Manufacturers (2017-2022) & (Mg)
Table 15. Global Defensin Sales Share by Manufacturers (2017-2022)
Table 16. Global Defensin Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Defensin Revenue Share by Manufacturers (2017-2022)
Table 18. Defensin Price by Manufacturers (2017-2022) &(US$/Mg)
Table 19. Global Defensin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Defensin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Defensin as of 2021)
Table 21. Defensin Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Defensin Product Offered
Table 23. Date of Manufacturers Enter into Defensin Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Defensin Sales by Type (2017-2022) & (Mg)
Table 26. Global Defensin Sales by Type (2023-2028) & (Mg)
Table 27. Global Defensin Sales Share by Type (2017-2022)
Table 28. Global Defensin Sales Share by Type (2023-2028)
Table 29. Global Defensin Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Defensin Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Defensin Revenue Share by Type (2017-2022)
Table 32. Global Defensin Revenue Share by Type (2023-2028)
Table 33. Defensin Price by Type (2017-2022) & (US$/Mg)
Table 34. Global Defensin Price Forecast by Type (2023-2028) & (US$/Mg)
Table 35. Global Defensin Sales by Application (2017-2022) & (Mg)
Table 36. Global Defensin Sales by Application (2023-2028) & (Mg)
Table 37. Global Defensin Sales Share by Application (2017-2022)
Table 38. Global Defensin Sales Share by Application (2023-2028)
Table 39. Global Defensin Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Defensin Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Defensin Revenue Share by Application (2017-2022)
Table 42. Global Defensin Revenue Share by Application (2023-2028)
Table 43. Defensin Price by Application (2017-2022) & (US$/Mg)
Table 44. Global Defensin Price Forecast by Application (2023-2028) & (US$/Mg)
Table 45. North America Defensin Sales by Type (2017-2022) & (Mg)
Table 46. North America Defensin Sales by Type (2023-2028) & (Mg)
Table 47. North America Defensin Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Defensin Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Defensin Sales by Application (2017-2022) & (Mg)
Table 50. North America Defensin Sales by Application (2023-2028) & (Mg)
Table 51. North America Defensin Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Defensin Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Defensin Sales by Country (2017-2022) & (Mg)
Table 54. North America Defensin Sales by Country (2023-2028) & (Mg)
Table 55. North America Defensin Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Defensin Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Defensin Sales by Type (2017-2022) & (Mg)
Table 58. Europe Defensin Sales by Type (2023-2028) & (Mg)
Table 59. Europe Defensin Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Defensin Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Defensin Sales by Application (2017-2022) & (Mg)
Table 62. Europe Defensin Sales by Application (2023-2028) & (Mg)
Table 63. Europe Defensin Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Defensin Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Defensin Sales by Country (2017-2022) & (Mg)
Table 66. Europe Defensin Sales by Country (2023-2028) & (Mg)
Table 67. Europe Defensin Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Defensin Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Defensin Sales by Type (2017-2022) & (Mg)
Table 70. Asia Pacific Defensin Sales by Type (2023-2028) & (Mg)
Table 71. Asia Pacific Defensin Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Defensin Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Defensin Sales by Application (2017-2022) & (Mg)
Table 74. Asia Pacific Defensin Sales by Application (2023-2028) & (Mg)
Table 75. Asia Pacific Defensin Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Defensin Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Defensin Sales by Region (2017-2022) & (Mg)
Table 78. Asia Pacific Defensin Sales by Region (2023-2028) & (Mg)
Table 79. Asia Pacific Defensin Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Defensin Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Defensin Sales by Type (2017-2022) & (Mg)
Table 82. Latin America Defensin Sales by Type (2023-2028) & (Mg)
Table 83. Latin America Defensin Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Defensin Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Defensin Sales by Application (2017-2022) & (Mg)
Table 86. Latin America Defensin Sales by Application (2023-2028) & (Mg)
Table 87. Latin America Defensin Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Defensin Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Defensin Sales by Country (2017-2022) & (Mg)
Table 90. Latin America Defensin Sales by Country (2023-2028) & (Mg)
Table 91. Latin America Defensin Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Defensin Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Defensin Sales by Type (2017-2022) & (Mg)
Table 94. Middle East and Africa Defensin Sales by Type (2023-2028) & (Mg)
Table 95. Middle East and Africa Defensin Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Defensin Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Defensin Sales by Application (2017-2022) & (Mg)
Table 98. Middle East and Africa Defensin Sales by Application (2023-2028) & (Mg)
Table 99. Middle East and Africa Defensin Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Defensin Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Defensin Sales by Country (2017-2022) & (Mg)
Table 102. Middle East and Africa Defensin Sales by Country (2023-2028) & (Mg)
Table 103. Middle East and Africa Defensin Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Defensin Revenue by Country (2023-2028) & (US$ Million)
Table 105. Hycult Biotech Corporation Information
Table 106. Hycult Biotech Description and Major Businesses
Table 107. Hycult Biotech Defensin Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 108. Hycult Biotech Defensin Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Hycult Biotech Recent Developments
Table 110. Cloud Clone Corporation Information
Table 111. Cloud Clone Description and Major Businesses
Table 112. Cloud Clone Defensin Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 113. Cloud Clone Defensin Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Cloud Clone Recent Developments
Table 115. GL Biochem Corporation Information
Table 116. GL Biochem Description and Major Businesses
Table 117. GL Biochem Defensin Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 118. GL Biochem Defensin Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. GL Biochem Recent Developments
Table 120. Peptide Institute Corporation Information
Table 121. Peptide Institute Description and Major Businesses
Table 122. Peptide Institute Defensin Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 123. Peptide Institute Defensin Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Peptide Institute Recent Developments
Table 125. Go Top Peptide Biotech Corporation Information
Table 126. Go Top Peptide Biotech Description and Major Businesses
Table 127. Go Top Peptide Biotech Defensin Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 128. Go Top Peptide Biotech Defensin Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Go Top Peptide Biotech Recent Developments
Table 130. Cedarlane Corporation Information
Table 131. Cedarlane Description and Major Businesses
Table 132. Cedarlane Defensin Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 133. Cedarlane Defensin Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Cedarlane Recent Developments
Table 135. ProSpec-Tany Corporation Information
Table 136. ProSpec-Tany Description and Major Businesses
Table 137. ProSpec-Tany Defensin Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 138. ProSpec-Tany Defensin Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. ProSpec-Tany Recent Developments
Table 140. Abbexa Corporation Information
Table 141. Abbexa Description and Major Businesses
Table 142. Abbexa Defensin Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 143. Abbexa Defensin Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Abbexa Recent Developments
Table 145. AnaSpec Corporation Information
Table 146. AnaSpec Description and Major Businesses
Table 147. AnaSpec Defensin Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 148. AnaSpec Defensin Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. AnaSpec Recent Developments
Table 150. Hangzhou Taijia Biotech Corporation Information
Table 151. Hangzhou Taijia Biotech Description and Major Businesses
Table 152. Hangzhou Taijia Biotech Defensin Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2017-2022)
Table 153. Hangzhou Taijia Biotech Defensin Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Hangzhou Taijia Biotech Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Defensin Distributors List
Table 158. Defensin Customers List
Table 159. Defensin Market Trends
Table 160. Defensin Market Drivers
Table 161. Defensin Market Challenges
Table 162. Defensin Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Defensin Product Picture
Figure 3. Global Defensin Market Share by Type in 2021 & 2028
Figure 3. α-Defensin Product Picture
Figure 4. β-Defensin Product Picture
Figure 5. Global Defensin Market Share by Application in 2021 & 2028
Figure 6. Scientific Research
Figure 7. Medical
Figure 8. Others
Figure 9. Defensin Report Years Considered
Figure 10. Global Defensin Sales 2017-2028 (Mg)
Figure 11. Global Defensin Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Defensin Revenue 2017-2028 (US$ Million)
Figure 13. Global Defensin Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Defensin Sales Market Share by Region (2017-2022)
Figure 15. Global Defensin Sales Market Share by Region (2023-2028)
Figure 16. North America Defensin Sales YoY (2017-2028) & (Mg)
Figure 17. North America Defensin Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Defensin Sales YoY (2017-2028) & (Mg)
Figure 19. Europe Defensin Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Defensin Sales YoY (2017-2028) & (Mg)
Figure 21. Asia-Pacific Defensin Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Defensin Sales YoY (2017-2028) & (Mg)
Figure 23. Latin America Defensin Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Defensin Sales YoY (2017-2028) & (Mg)
Figure 25. Middle East & Africa Defensin Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Defensin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Defensin in the World: Market Share by Defensin Revenue in 2021
Figure 28. Global Defensin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Defensin Sales Market Share by Type (2017-2028)
Figure 30. Global Defensin Revenue Market Share by Type (2017-2028)
Figure 31. Global Defensin Sales Market Share by Application (2017-2028)
Figure 32. Global Defensin Revenue Market Share by Application (2017-2028)
Figure 33. North America Defensin Sales Market Share by Type (2017-2028)
Figure 34. North America Defensin Revenue Market Share by Type (2017-2028)
Figure 35. North America Defensin Sales Market Share by Application (2017-2028)
Figure 36. North America Defensin Revenue Market Share by Application (2017-2028)
Figure 37. North America Defensin Sales Share by Country (2017-2028)
Figure 38. North America Defensin Revenue Share by Country (2017-2028)
Figure 39. United States Defensin Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Defensin Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Defensin Sales Market Share by Type (2017-2028)
Figure 42. Europe Defensin Revenue Market Share by Type (2017-2028)
Figure 43. Europe Defensin Sales Market Share by Application (2017-2028)
Figure 44. Europe Defensin Revenue Market Share by Application (2017-2028)
Figure 45. Europe Defensin Sales Share by Country (2017-2028)
Figure 46. Europe Defensin Revenue Share by Country (2017-2028)
Figure 47. Germany Defensin Revenue (2017-2028) & (US$ Million)
Figure 48. France Defensin Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Defensin Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Defensin Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Defensin Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Defensin Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Defensin Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Defensin Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Defensin Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Defensin Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Defensin Revenue Share by Region (2017-2028)
Figure 58. China Defensin Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Defensin Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Defensin Revenue (2017-2028) & (US$ Million)
Figure 61. India Defensin Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Defensin Revenue (2017-2028) & (US$ Million)
Figure 63. China Taiwan Defensin Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Defensin Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Defensin Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Defensin Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Defensin Sales Market Share by Type (2017-2028)
Figure 68. Latin America Defensin Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Defensin Sales Market Share by Application (2017-2028)
Figure 70. Latin America Defensin Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Defensin Sales Share by Country (2017-2028)
Figure 72. Latin America Defensin Revenue Share by Country (2017-2028)
Figure 73. Mexico Defensin Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Defensin Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Defensin Revenue (2017-2028) & (US$ Million)
Figure 76. Colombia Defensin Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Defensin Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Defensin Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Defensin Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Defensin Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Defensin Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Defensin Revenue Share by Country (2017-2028)
Figure 83. Turkey Defensin Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Defensin Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Defensin Revenue (2017-2028) & (US$ Million)
Figure 86. Defensin Value Chain
Figure 87. Defensin Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

---